To study the safety and effect of tranexamic acid drug in transurethral resection of prostate surgery for benign prostatic hyperplasia patients.
Phase 4
- Conditions
- Health Condition 1: N996- Intraoperative hemorrhage and hematoma of a genitourinary system organ or structure complicating a procedureHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2023/08/056336
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients who required surgical intervention for BPH
2. Prostate weight (30 -100 cc)
3. Preoperative Hb more than 10 mg/dl
4. Age 50 to 80 years
5. ASA ⩽III
6. Age specific PSA range
Exclusion Criteria
1.Patient refusal
2.Coagulopathies
3.Dual anti-platelets or clopidogrel drugs users
4.Ischaemic heart diseases and arrhythmia
5.History of PTE and DVT
6.History of CVA
7.Renal failure (serum creatinine >1.3 mg / dl)
8.Carcinoma of prostate
9.History of tranexamic acid sensitivity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method